Pricing

EyePoint Pharmaceuticals Inc (EYPT)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
LABORATORY ANALYTICAL INSTRUMENTS
CEO:
Nancy S. Lurker
Employees:
120
480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, 02472
617-926-5000

Are you looking for this stock instead?

Stock Split History
DateRatio
2008-06-11 1:4
2020-12-09 1:10
EyePoint Pharmaceuticals, Inc. provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema. DEXYCU, a dexamethasone intraocular suspension, for the treatment of post-operative ocular inflammation, including treatment following cataract surgery. It is also developing EYP-1901, a twice-yearly bioerodible formulation of tyrosine kinase inhibitor for the. treatment of wet age-related macular degeneration, diabetic retinopathy and retinal vein occlusion.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available